TENAGRITY SOLUTIONS, LLC lobbying for KARDIOGENICS, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · posted Oct 20, 2025

Bills named in this filing 1

HR 4016
Department of Defense Appropriations Act, 2026

Lobbying activity 4

Health Issues

Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)

Budget/Appropriations

Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution

Defense

Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution

Medical/Disease Research/Clinical Labs

Discussions with congressional offices and HHS re: client and how their product and work could save lives